Literature DB >> 17785827

The type 1 diabetes locus Idd6 controls TLR1 expression.

David Vallois1, Christina H Grimm, Philip Avner, Christian Boitard, Ute Christine Rogner.   

Abstract

The Idd6 locus on mouse chromosome 6, which controls the development of type 1 diabetes in the NOD mouse, affects proliferation rates of T cells and the activity of regulatory CD4+CD25+ T cells. Using a transcriptional profiling approach, we show that splenocytes and thymocytes from diabetes-resistant Idd6 NOD.C3H-congenic mouse strains exhibit a constitutive and specific down-regulation of Toll-like receptor 1 (Tlr1) gene expression compared with diabetes prone NOD mice. This phenotype correlates with a diminished proliferation capacity of both CD4+CD25- effector and CD4+CD25+ regulatory T cells upon in vitro stimulation of the TLR1/TLR2 pathway by the ligand palmitoyl-3-cysteine-serine-lysine 4, and with the constitutive down-regulation of Tnf-alpha and IL-6 in macrophages of Idd6- congenic mice. These data suggest that TLR1 is involved in the regulation of mechanisms that impinge on diabetes development in the NOD mouse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785827     DOI: 10.4049/jimmunol.179.6.3896

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

Review 2.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 3.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

4.  Inhibition of type 1 diabetes by upregulation of the circadian rhythm-related aryl hydrocarbon receptor nuclear translocator-like 2.

Authors:  Chen-Xia He; Nicolas Prevot; Christian Boitard; Philip Avner; Ute C Rogner
Journal:  Immunogenetics       Date:  2010-07-30       Impact factor: 2.846

Review 5.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

6.  Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.

Authors:  Agnieszka Jezierska; Irina A Kolosova; Alexander D Verin
Journal:  Curr Signal Transduct Ther       Date:  2011

7.  Genome-wide transcriptional analyses of islet-specific CD4+ T cells identify Idd9 genes controlling diabetogenic T cell function.

Authors:  Gregory J Berry; Christine Frielle; Thaiphi Luu; Anna C Salzberg; Daniel B Rainbow; Linda S Wicker; Hanspeter Waldner
Journal:  J Immunol       Date:  2015-02-11       Impact factor: 5.422

8.  Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.

Authors:  Gordon C Weir; Mario R Ehlers; Kristina M Harris; Sai Kanaparthi; Alice Long; Deborah Phippard; Lia J Weiner; Brett Jepson; James G McNamara; Maria Koulmanda; Terry B Strom
Journal:  Pediatr Diabetes       Date:  2018-05-07       Impact factor: 4.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.